Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan
· Delayed Price · Currency is TWD 15.10
+0.60 (4.14%)
Apr 2, 2025, 2:59 PM CST
Mercury Biopharmaceutical Market Cap
Mercury Biopharmaceutical has a market cap or net worth of 6.12 billion as of April 2, 2025. Its market cap has decreased by -14.01% in one year.
Market Cap
6.12B
Enterprise Value
5.89B
Revenue
5.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.10
Market Cap Chart
Since December 23, 2022, Mercury Biopharmaceutical's market cap has increased from 5.10B to 6.12B, an increase of 19.85%. That is a compound annual growth rate of 8.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 6.12B | 11.25% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 176.51B |
| Caliway Biopharmaceuticals | 113.99B |
| Bora Pharmaceuticals Co., LTD. | 71.78B |
| Lotus Pharmaceutical | 62.09B |
| Oneness Biotech | 32.98B |
| Lumosa Therapeutics | 29.22B |
| Pegavision | 28.08B |
| Polaris Group | 27.65B |